title: Effectiveness of a five times daily triple therapy regimen against Helicobacter pylori.
authors.affiliation: Centre for Digestive Diseases, General Infirmary at Leeds, UK.
authors.forename: D A
authors.initials: DA
authors.lastname: Lynch
authors.forename: G M
authors.initials: GM
authors.lastname: Sobala
authors.forename: B
authors.initials: B
authors.lastname: Gallacher
authors.forename: M F
authors.initials: MF
authors.lastname: Dixon
authors.forename: A T
authors.initials: AT
authors.lastname: Axon
mesh_terms: D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000209:etiology; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D008795:Metronidazole / Q000494:pharmacology; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D010118:Oxytetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D011899:Ranitidine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D008795:Metronidazole; D011899:Ranitidine; C002791:bismuth tripotassium dicitrate; D010118:Oxytetracycline